Medications for Small Lymphocytic Lymphoma

6 results

  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
    Medication Details

  • brukinsa - zanubrutinib capsule

    (Zanubrutinib)
    Beone Medicines Usa, Inc.
    BRUKINSA is a kinase inhibitor for adults with mantle cell lymphoma, Waldenström's macroglobulinemia, chronic lymphocytic leukemia or small lymphocytic lymphoma, relapsed/refractory marginal zone lymphoma, and relapsed/refractory follicular lymphoma (with obinutuzumab).
    Medication Details
    Drug Interactions

  • calquence - acalabrutinib tablet, film coated

    (Acalabrutinib)
    Astrazeneca Pharmaceuticals Lp
    CALQUENCE treats adults with mantle cell lymphoma (MCL) — either previously untreated (with bendamustine and rituximab, when ineligible for stem cell transplant) or after prior therapy — and adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
    Medication Details
    Drug Interactions

  • copiktra - duvelisib capsule

    (Duvelisib)
    Secura Bio, Inc
    Copiktra treats adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior systemic therapies. Not indicated as initial or second-line treatment due to increased risk of treatment-related mortality.
    Medication Details
    Drug Interactions

  • jaypirca - pirtobrutinib tablet, coated

    (Pirtobrutinib)
    Eli Lilly And Company
    Jaypirca treats adults with relapsed or refractory mantle cell lymphoma (MCL) after two or more prior therapies including a BTK inhibitor, and adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) after a covalent BTK inhibitor.
    Medication Details
    Drug Interactions

  • venclexta - venetoclax

    (Venetoclax)
    Abbvie Inc.
    Venclexta treats adult CLL or SLL patients, and newly diagnosed AML in adults 75+ or with comorbidities preventing intensive chemotherapy, used in combination with azacitidine, decitabine, or low-dose cytarabine.
    Medication Details
    Drug Interactions